Cardiovascular risk factor investigation: A pediatric issue

International Journal of General Medicine

Volumn 6, Issue , 2013, Pages 57-66

  Rodrigues, Anabel N ^a   Abreu, Glaucia R ^b   Resende, Rogério S ^a   Goncalves, Washington L S ^a   Gouvea, Alves Sonia ^b  

^a School of Medicine University Center of Espírito Santo   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Cardiovascular risk; Children; Dyslipidemia; Hypertension; Metabolic syndrome; Obesity; Sedentariness

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTERIAL PRESSURE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHILD BEHAVIOR; DISEASE ASSOCIATION; DYSLIPIDEMIA; EXERCISE; FEEDING BEHAVIOR; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; OXYGEN CONSUMPTION; SEDENTARY LIFESTYLE;

EID: 84875354012     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S41480     Document Type: Article

References (112)

1. Kelishadi R, Zadegan NS, Naderi GA, Asgary S, Bashardoust N. Atherosclerosis risk factors in children and adolescents with or without family history of premature coronary artery disease. Med Sci Monit. 2002;8:425-429.
2. Strong WB, Kelder SH. Pediatric preventive cardiology. In: Manson JE, Ridker PM, Gaziano DM, Hennekens CH, editors. Prevention of Myocardial Infarction. Oxford: Oxford University Press; 1996:433-459.
3. Lotufo PA. Novos conceitos sobre uma Velha Realidade. In: Mion D Jr, Nobre F, editors. Risco Cardiovascular Global. São Paulo: Lemos Editoria; 1999:31-43.
4. Pellanda LC, Echenique L, Barcellos LMA, MaccarI J, Borges FK, Zen BL. Doença cardíaca isquêmica: a prevenção inicia durante a infância. J Pediatr. 2002;78:91-96.
5. Massin M, Vandoorne C, Coremans C, Lepage P, Scheen A. Preventive cardiology: strategies in children. Rev Med Liege. 2002;57:207-212.
6. Michaelsen KF, Dyerberg J, Falk E, et al. Children, fat and cardiovascular diseases. Ugeskr Laeger. 2002;164:1334-1338. Danish.
7. Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002;106:143-160.
8. Srinivasan SR, Myers L, Berenson GS. Distribution and correlates of non-high-density lipoprotein cholesterol in children: the Bogalusa Heart Study. Pediatrics. 2002;110:29-32.
9. Lenfant C, Savage PJ. The early natural history of atherosclerosis and hypertension in the young: National Institutes of Health perspectives. Am J Med Sci. 1995;310 Suppl 1:S3-S7.
10. Purath J, Lansinger T, Ragheb C. Cardiac risk evaluation for elementary school children. Public Health Nurs. 1995;12:189-195.
11. Gerber ZRS, Zielinsky P. Fatores de Risco de Aterosclerose na infância. Um Estudo Epidemiológico. Arq Bras Cardiol. 1997;69:231-236.
12. Akerblom HK, Viikari J, Raitakari OT, Uhari M. Cardiovascular risk in Young Finns Study: general outline and recent developments. Ann Med. 1999;31:45-54.
13. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291:2847-2850.
14. Eckel RH, York DA, Rössner S, et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation. 2004;110:2968-2975.
15. Rodrigues AN, Moyses MR, Bissoli NS, Pires JGP, Abreu GR. Cardiovascular risk factor in a population of Brazilian schoolchildren. Braz J Med Biol Res. 2006;39:1637-1642.
16. Rodrigues AN, Perez AJ, Pires JG, et al. Cardiovascular risk factors, their associations and presence of metabolic syndrome in adolescents. J Pediatr (Rio J). 2009;85:55-60.
17. Santos MG, Pegoraro M, Sandrini F, Macuco EC. Fatores de risco no desenvolvimento da aterosclerose na infância e adolescência. Arq Brás Cardiol. 2008;90:301-308.
18. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1996;132:612-628.
19. Esrey KL, Joseph L, Grover SA. Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. J Clin Epidemiol. 1996;49:211-216.
20. Guedes DP, Guedes JERP. Atividade física, aptidão cardiorrespiratória, composição da dieta e fatores de risco predisponentes às doenças cardiovasculares. Arq Bras Cardiol. 2001;77:243-250.
21. Austin MA. Epidemiology of hypertriglyceridemia and cardiovascular disease. Am J Cardiol. 1999;83:13F-16F.
22. Coelho OR, Ueti OM, Almeida A. Lípides como fator de risco. In: Mion D Jr, Nobre F, editors. Risco Cardiovascular Global. São Paulo: Lemos Editorial; 1999:45-64.
23. Françoso LA, Coates V. Evidências anatomopatológicas do início da aterosclerose na infância e adolescência. Arq Bras Cardiol. 2002;78: 131-136.
24. Massin M, Coremans C, Palumbo L, Lepage P. Preventive cardiology: the role of the pediatrician. Ital J Pediatr. 2002;28:98-104.
25. Brotons C, Ribera A, Perich RM, et al. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis. 1998;139:1-9.
26. Halpern A, Mancini MC, Magalhães MEC, et al. Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr. 2010;2:55.
27. Giuliano ICB, Caramelli B. Dislipidemias em crianças e adolescentes. Rev Soc Cardiol Estado São Paulo. 2005;6:535-543.
28. Guimarães AC, Lima A, Mota E, et al. The cholesterol level of a selected Brazilian salaried population: biological and socioeconomic influences. CVD Prev. 1998;1:306-317.
29. Guimarães ICB, Guimarães AC. Prevalence of cardiovascular risk factors in selected samples of schoolchildren - socioeconomic influence. Prev Cardiol. 2005;8:23-28.
30. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
31. Gaziano DM, Hennekens CH, editors. Prevention of Myocardial Infarction. Oxford: Oxford University Press; 1996:433-459.
32. Golding J, Emmet PM, Rogers IS. Does breast feeding have any impact on non-infectious, non-allergic disorders Early Hum Dev. 1997; 49 Suppl:S131-S142.
33. Forti N, Giannini SD, Diament J, et al. Fatores de risco para aterosclerose em filhos de pacientes com doença coronariana precoce. Arq Bras Cardiol. 1996;66:119-123.
34. Rodrigues AN, Abreu GR, Gouvêa SA. Cardiovascular risk investigation: when should it start? In: Gasparyan AY, editor. Cardiovascular Risk Factors. Rijeka, Croatia: InTech; 2012.
35. Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, González-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail. 2002;4:331-336.
36. Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 2000;36:1587-1593.
37. Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003; 107(11):1486-1491.
38. Toprak A, Kandavar R, Toprak D, et al. C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study). BMC Cardiovasc Disord. 2011;11:78.
39. Kelishadi R. Inflammation-induced atherosclerosis as a target 1 for prevention of cardiovascular diseases from early life. Open Cardiovasc Med J. 2010;4:24-29.
40. Sorensen TIA. The genetics of obesity. Metabolism. 1995;44 Suppl 3: 4-6.
41. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology and demographics. Pediatrics. 1998;101 Suppl 3: 497-504.
42. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Smith GD. Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr. 1998;67:1111-1118.
43. VanHorn L, Greenland P. Prevention of coronary artery disease is a pediatric problem. JAMA. 1997;278:1779-1780.
44. Kikuchi DA, Srinivasan SR, Harsha DW, Webber LS, Sellers TA, Berenson GS. Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study. Prev Med. 1992;21:177-190.
45. Zanella MT. Obesidade. In: Mion D Jr, Nobre F, editors. Risco Cardiovascular Global. São Paulo: Lemos Editorial; 1999: 103-114.
46. Cali AM, Caprio S. Obesity in children and adolescents. Clin Endocrinol Metab. 2008;93:S31-S36.
47. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and adult cardiovascular disease: a systematic review. Int J Obes (Lond). 2010;34:18-28.
48. Coronelli CLS, Moura EC. Hipercolesterolemia em escolares e seus fatores de risco. Rev Saude Publica. 2003;37:24-31.
49. Alves JGB, Siqueira PP, Figueiroa JN. Overweight and physical inactivity in children living in favelas in the metropolitan region of Recife, Brazil. J Pediatr (Rio J). 2009;85:67-71.
50. Daniels S., Arnett DK, Eckel RH, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation. 2005;111:1999-2012.
51. Buiten C, Metzger B. Childhood obesity and risk of cardiovascular disease: a review of the science. Pediatr Nurs. 2000;26:13-18.
52. Waters E, de Silva-Sanigorski A, Hall BJ, et al. Interventions for preventing obesity in children. Cochrane Database Syst Rev. 2011;12:CD001871.
53. Summerball CD, Moore HJ, Vogele C, et al. Evidence-based recommendations for the development of obesity prevention programs targeted at preschool children. Obes Rev. 2012;13 Suppl 1:129-132.
54. Giugliano R, Melo ALP. Diagnóstico de sobrepeso e obesidade em escolares: utilização do índice de massa corporal segundo padrão internacional. J Pediatr. 2004;80:129-134.
55. Mello ED, Luft VC, Meyer F. Obesidade infantil: como podemos ser eficazes? J Pediatr. 2004;80:173-182.
56. Bueno MB, Marchioni DM, Fisberg RM. Changes in the nutritional status of children in public day care facilities in the municipality of São Paulo, Brazil. Rev Panam Salud Publica. 2003;14:165-170.
57. Silva DAS, Pelegrini A, Petroski EL, Gaya ACA. Comparison between the growth of Brazilian children and adolescents and the reference growth charts: data from a Brazilian project. J Pediatr (Rio J). 2010;86:115-120.
58. Abrantes MM, Lamounier JA, Colosimo EA. Prevalência de sobrepeso e obesidade em crianças e adolescentes das regiões Sudeste e Nordeste. J Pediatr. 2002;78:335-340.
59. Moura AA, Silva MAM, Ferraz MRMT, Rivera IR. Prevalência de pressão arterial elevada em escolares e adolescentes de Maceió. J Pediatr. 2004;80:35-40.
60. O'Brien SH, Holubkoy R, Reis EC. Identification, evaluation, and management of obesity in an academic primary care center. Pediatrics. 2004;114:154-159.
61. Reavens GM, Lithell H, Landsberg L. Hypertension and associated abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:74-81.
62. Brandão AP, Brandão AA, Berenson GS, Fuster V. Metabolic syndrome in children and adolescents. Arq Bras Cardiol. 2005;85:79-81.
63. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
64. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
65. National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda (MD): National Institutes of Health; 2002.
66. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistence (EGIR). Diabet Med. 1999;16:442-443.
67. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-827.
68. Csábi G, Török K, Jeges S, Molnár D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159: 91-94.
69. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes. 2002;51:204-209.
70. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
71. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1999;22 Suppl 1: S5-S19.
72. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
73. Taskinen MR. Diabetic dyslipidemia: from basic research to clinical practice. Diabetologia. 2003;46:733-749.
74. Morton NM, Holmes MC, Fievet C, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity and glucose tolerance in 11 beta hydroxyesteroid dehydrogenase type 1 null mice. J Biol Chem. 2001;276:41293-41300.
75. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374.
76. Cadernos de Atenção Básica. Hipertensão Arterial Sistêmica. Brasilia: Ministério da Saúde; 2006.
77. Falkner B, Gidding SS, Portman R, Rosner B. Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics. 2008;122:238-242.
78. Raj M. Essential hypertension in adolescents and children: recent advances in causative mechanisms. Indian J Endocrinol Metab. 2011;15 Suppl 4: S367-S373.
79. Oliveira RG, Lamounier JA, Oliveira ADB, Castro MDR, Oliveira JS. Blood pressure in school children and adolescents - the Belo Horizonte study. J Pediatr (Rio J). 1999;75:256-266. Portuguese.
80. Salgado CM, Carvalhaes JTA. Arterial hypertension in childhood. J Pediatr (Rio J). 2003;79 Suppl 1:S115-S124.
81. Mcmillen C, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005;85:571-633.
82. Carlson SH, Oparil S, Chen YF, Wyss JM. Blood pressure and NaClsensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice. Hypertension. 2002;39: 214-218.
83. Rosa AA, Ribeiro JP. High blood pressure in children and adolescents: determinant factors. J Pediatr (Rio J). 1999;75:75-82.
84. Kavey REW, Daniels S., Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107:1562-1566.
85. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
86. Lieberman E. Hypertension in childhood and adolescence. In: Kaplan NM, editor. Clinical Hypertension, 8th ed. Baltimore: Williams & Wilkins; 2002:512-526.
87. Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensão/Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol. 2010;95:1-51.
88. Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002;40:441-447.
89. Campana ANNB, Tavares MCGCF. Avaliação da Imagem Corporal:Instrumentos e Diretrizes para a Pesquisa. São Paulo: Phorte; 2009.
90. European Society of Hypertension. Guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
91. No authors listed. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, phase I. JAMA. 1992;267:1213-1220.
92. Monteiro CA, Conde WL, Castro IR. The changing relationship between education and risk of obesity in Brazil (1975-1997). Cad Saude Publica. 2003;19 Suppl 1:S67-S75. Portuguese.
93. Rosa ML, Fonseca VM, Oigman G, Mesquita ET. Arterial prehypertension and elevated pulse pressure in adolescents: prevalence and associated factors. Arq Bras Cardiol. 2006;87:46-53. Portuguese.
94. Srinivasan SR, Myers L, Berenson GS. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study. Hypertension. 2006;48:33-39.
95. Rodrigues AN, Coelho LC, Goncalves WL, et al. Stiffness of the large arteries in individuals with and without Down syndrome. Vasc Health Risk Manag. 2011;7:375-381.
96. Rondon MUPB, Forjaz CLM, Nunes N, Amaral SL, Barretto ACPB, Negrão CE. Comparação entre a prescrição de intensidade de treinamento físico baseada na avaliação ergométrica convencional e na ergoespirometria. Arq Bras Cardiol. 1998;70:159-166.
97. Strong WB, Malina RM, Blimkie CJ, et al. Evidence based physical activity for school-age youth. J Pediatr. 2005;146:732-737.
98. Boreham C, Riddoch C. The physical activity, fitness and health of children. J Sports Sci. 2001;19:915-929.
99. Twisk JW. Physical activity guidelines for children and adolescents: a critical review. Sports Med. 2001;31:617-627.
100. Gordon-Larsen P, McMurray RG, Popkin BM. Determinants of adolescent physical activity and inactivity patterns. Pediatrics. 2000; 105:E83.
101. Freedman DS, Srinivasan SR, Valdez RA, Williamson DF, Berenson GS. Secular increases in relative weight and adiposity among children over two decades: the Bogalusa Heart Study. Pediatrics. 1997;99:420-426.
102. Lippo BRS, Silva IM, Aca CRP, Lira PIC, Silva GAP, Motta MEFA. Determinants of physical inactivity among urban adolescents. J Pediatr (Rio J). 2010;86:520-524.
103. Al-Hazaa HM. Physical activity, fitness and fatness among Saudi children and adolescents: implications for cardiovascular health. Saudi Med J. 2002;23:144-150.
104. Armstrong N, Welsman JR. Assessment and interpretation of aerobic fitness in children and adolescents. Exerc Sport Sci Rev. 1994;22:435-476.
105. Obert P, Mandigout S, Nottin S, Vinet A, N'Guyen D, Lecoq A. Cardiovascular responses to endurance training in children: effect of gender. Eur J Clin Invest. 2003;33:199-208.
106. Tolfrey K, Campbell IG, Jone AM. Selected predictor variables and the lipid-lipoprotein profile of prepubertal girls and boys. Med Sci Sports Exerc. 1999;31:1550-1557.
107. Shea S, Basch CE, Gutin B, et al. The rate of increase in blood pressure in children 5 years of age is related to changes in aerobic fitness and body mass index. Pediatrics. 1994;94:465-470.
108. Tourinho Filho H, Tourinho LSPR. Crianças, adolescentes e atividade física: aspectos maturacionais e funcionais. Rev Paul Educ Fis. 1998;12:71-84.
109. Turley KR, Wilmore JH. Cardiovascular responses to treadmill and cycle ergometer exercise in children and adults. J Appl Physiol. 1997;83:948-957.
110. Thomas NE, Baker JS, Davies B. Established and recently identified coronary heart disease risk factors in young people: the influence of physical activity and physical fitness. Sports Med. 2003;33:633-650.
111. Bouchard C, Dionne FT, Simoneau JA, Boulay MR. Genetics of aerobic and anaerobic performances. Exerc Sport Sci Rev. 1992;20:27-58.
112. McMurray RG, Ainsworth BE, Harrell JS, Griggs TR, Williams OD. Is physical activity or aerobic power more influential at reducing cardiovascular disease risk factors? Med Sci Sports Exerc. 1998;30:1521-1529.